What is vTv Therapeutics Inc (VTVT) stock price today?

vTv Therapeutics Inc (VTVT) currently trades at $32.24 per share. The stock has a market capitalization of $125.92M and a P/E ratio of —x.

Is VTVT stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, vTv Therapeutics Inc has a Smart Value Score of 26/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is vTv Therapeutics Inc's revenue and earnings?

vTv Therapeutics Inc has trailing twelve-month (TTM) revenue of $17000.00 with profit margins of 0.00%. Earnings per share (EPS) is $-3.20.

VTVT

vTv Therapeutics Inc

NASDAQ: VTVT · HEALTHCARE · BIOTECHNOLOGY

$32.24

+3.10% today

Updated 2026-04-30

Market cap

$125.92M

P/E ratio

—

P/S ratio

14,852.65x

EPS (TTM)

$-3.20

Dividend yield

—

52W range

$14 – $44

Volume

0.1M

Market cap

$125.92M

P/E ratio

—

P/S ratio

14,852.65x

EPS (TTM)

$-3.20

Dividend yield

—

52W range

$14 – $44

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$53.33

+65.42%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-9.25M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$2.02M	$9000.00	$1.02M	$0.00	$17000.00
Net income	$-19.16M	$-20.25M	$-18.46M	$-26.97M	$-7.14M
EPS	—	—	—	—	$-3.20
Free cash flow	$-15.27M	$-19.08M	$-25.31M	$-25.25M	$-9.25M
Profit margin	-949.65%	-225,000.00%	-1,815.34%	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
VTVT	$125.92M	26	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

vTv Therapeutics Inc trades at $32.24. Our Smart Value Score of 26/100 indicates the stock is weak. TTM revenue stands at $17000.00.

Frequently asked questions

What is vTv Therapeutics Inc's stock price?

vTv Therapeutics Inc (VTVT) trades at $32.24.

Is vTv Therapeutics Inc overvalued?

Smart Value Score 26/100 (Grade F, Strong Sell).

What is the price target of vTv Therapeutics Inc (VTVT)?

The analyst target price is $53.33, representing +65.4% upside from the current price of $32.24.

What is vTv Therapeutics Inc's revenue?

TTM revenue is $17000.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio14,852.65x

ROE-78.90%

Beta0.40

50D MA$36.81

200D MA$28.38

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

VTVT vs LLY →VTVT vs JNJ →VTVT vs ABBV →Stock screener →